Application and prospect of organoids-on-chip in the study of nano-drug delivery systems

被引：0
|
作者：
Yang Y. [1 ]
Li M. [1 ]
Yao Z. [1 ]
Sun Q. [1 ]
Liu Y. [1 ]
Ge D. [1 ]
Sun B. [1 ]
机构：
[1] School of Chemical Engineering, Dalian University of Technology, Liaoning, Dalian
来源：
Huagong Xuebao/CIESC Journal | 2024年 / 75卷 / 04期
关键词：
cell biology; drug delivery; nanomaterials; organoids-on-chip; tissue engineering;
D O I：
10.11949/0438-1157.20231262
中图分类号：
学科分类号：
摘要：
Organoids are self-assembling three-dimensional multicellular structures derived from human stem cells, organ-specific progenitor cells or isolated tumor tissues, which could reproduce the key structural features and physiological functions of organs in vitro. As an in vitro culture platform for organoids, microfluidic chips provide opportunities to study the behavior of cells in heterogeneous populations and microenvironments. Therefore, they have become a powerful tool to assist human organ development research, disease modeling, and drug screening. Nanomaterials, as an advanced carrier for drug delivery, can significantly improve the therapeutic effects of drugs and have become the focus of new drug development. Organoids-on-chip not only provide a reliable platform for evaluating the safety and efficacy of nano-drug delivery systems, but also help the design of nanocarriers and personalized treatment. In this review, we give an update on the limitations of traditional two-dimensional cell models and animal models in nano-drug delivery systems evaluation, with an emphasis on the advantages of in vitro platforms by organoids-on-chip. It also summarized the recent application and development of organoids technology and future directions in nano-drug delivery systems. © 2024 Materials China. All rights reserved.
引用
收藏
页码：1209 / 1221
页数：12
相关论文
共 122 条
  • [21] Wei D S, Sun Y, Zhu H, Et al., Stimuli-responsive polymer-based nanosystems for cancer theranostics, ACS Nano, 17, 23, pp. 23223-23261, (2023)
  • [22] Khan R U, Shao J N, Liao J Y, Et al., pH-triggered cancer-targeting polymers: from extracellular accumulation to intracellular release, Nano Research, 16, 4, pp. 5155-5168, (2023)
  • [23] Nizamov T R, Iliasov A R, Vodopyanov S S, Et al., Study of cytotoxicity and internalization of redox-responsive iron oxide nanoparticles on PC-3 and 4T1 cancer cell lines, Pharmaceutics, 15, 1, (2022)
  • [24] Sheng Z J, Xu W P, Xu T J, Et al., New developments in liposomal drug delivery systems, China Pharmaceuticals, 24, 23, pp. 6-9, (2015)
  • [25] Hajj K A, Whitehead K A., Tools for translation: non-viral materials for therapeutic mRNA delivery, Nature Reviews Materials, 2, 10, (2017)
  • [26] Wang H, Dong L, Shao M J, Et al., Aloe-emodin nanoliposomemediated photodynamic therapy inhibits proliferation and promotes autophagy of human oral cancer CAL-27 cells, Journal of Modern Oncology, 29, 5, pp. 719-723, (2021)
  • [27] Zhong R B, Talebian S, Mendes B B, Et al., Hydrogels for RNA delivery, Nature Materials, 22, pp. 818-831, (2023)
  • [28] Peer D, Karp J M, Hong S, Et al., Nanocarriers as an emerging platform for cancer therapy, Nature Nanotechnology, 2, pp. 751-760, (2007)
  • [29] Vinogradov S V, Bronich T K, Kabanov A V., Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells, Advanced Drug Delivery Reviews, 54, 1, pp. 135-147, (2002)
  • [30] Vicent M J, Duncan R., Polymer conjugates: nanosized medicines for treating cancer, Trends in Biotechnology, 24, 1, pp. 39-47, (2006)
12345678910